» Articles » PMID: 30915526

Consultation on UTUC, Stockholm 2018 Aspects of Diagnosis of Upper Tract Urothelial Carcinoma

Overview
Journal World J Urol
Specialty Urology
Date 2019 Mar 28
PMID 30915526
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To summarize knowledge on upper urinary tract carcinoma (UTUC) regarding diagnostic procedures, risk factors and prognostic markers.

Methods: A scoping review approach was applied to search literature in Pubmed, Web of Science, and Embase. Consensus was reached through discussions at Consultation on UTUC in Stockholm, September 2018.

Results: Tumor stage and grade are the most important prognostic factors. CT urography (CTU) including corticomedullary phase is the preferred imaging modality. A clear tumor on CTU in combination with high-grade UTUC in urine cytology identifies high-risk UTUC, and in some cases indirect staging can be obtained. Bladder urine cytology has limited sensitivity, and in most cases ureterorenoscopy (URS) with in situ samples for cytology and histopathology are mandatory for exact diagnosis. Image-enhancing techniques, Image S1 and narrow-band imaging, may improve tumor detection at URS. Direct confocal laser endomicroscopy may help to define grade during URS. There is strong correlation between stage and grade, accordingly correct grading is crucial. The correlation is more pronounced using the 1999 WHO than the 2004 classification: however, the 1999 system risks greater interobserver variability. Using both systems is advisable. A number of tissue-based molecular markers have been studied. None has proven ready for use in clinical practice.

Conclusions: Correct grading and staging of UTUC are mandatory for adequate treatment decisions. Optimal diagnostic workup should include CTU with corticomedullary phase, URS with in situ cytology and biopsies. Both WHO classification systems (1999 and 2004) should be used to decrease risk of undergrading or overtreatment.

Citing Articles

Hematuria in the ER patient: optimizing detection of upper tract urothelial cancer - A pictorial essay.

Yasrab M, Crawford C, Chu L, Kawamoto S, Fishman E Emerg Radiol. 2025; .

PMID: 39812925 DOI: 10.1007/s10140-024-02308-z.


Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy.

Fukumoto K, Kanatani S, Jaremko G, West Z, Li Y, Takamatsu K JCI Insight. 2024; 9(14).

PMID: 39133649 PMC: 11383588. DOI: 10.1172/jci.insight.175751.


Same Organ, Two Cancers: Complete Analysis of Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas.

Vamesu S, Ursica O, Milea S, Deacu M, Aschie M, Mitroi A Medicina (Kaunas). 2024; 60(7).

PMID: 39064555 PMC: 11279004. DOI: 10.3390/medicina60071126.


MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.

Kobayashi G, Hayashi T, Sentani K, Uraoka N, Fukui T, Kido A Diagn Pathol. 2023; 18(1):106.

PMID: 37737200 PMC: 10515259. DOI: 10.1186/s13000-023-01392-y.


Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?.

Grahn A, Coleman J, Eriksson Y, Gabrielsson S, Madsen J, Tham E World J Urol. 2023; 41(12):3405-3411.

PMID: 37725130 PMC: 10693501. DOI: 10.1007/s00345-023-04597-4.


References
1.
Osther P . Risks of flexible ureterorenoscopy: pathophysiology and prevention. Urolithiasis. 2017; 46(1):59-67. DOI: 10.1007/s00240-017-1018-6. View

2.
Villa L, Haddad M, Capitanio U, Somani B, Cloutier J, Doizi S . Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long-Term Results from a High Volume Institution. J Urol. 2017; 199(1):66-73. DOI: 10.1016/j.juro.2017.07.088. View

3.
Epstein J, Amin M, Reuter V, Mostofi F . The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998; 22(12):1435-48. DOI: 10.1097/00000478-199812000-00001. View

4.
Bagrodia A, Audenet F, Pietzak E, Kim K, Murray K, Cha E . Genomic Profile of Urothelial Carcinoma of the Upper Tract from Ureteroscopic Biopsy: Feasibility and Validation Using Matched Radical Nephroureterectomy Specimens. Eur Urol Focus. 2018; 5(3):365-368. PMC: 7583604. DOI: 10.1016/j.euf.2018.01.005. View

5.
Helenius M, Dahlman P, Magnusson M, Lonnemark M, Magnusson A . Contrast enhancement in bladder tumors examined with CT urography using traditional scan phases. Acta Radiol. 2013; 55(9):1129-36. DOI: 10.1177/0284185113513762. View